KLK3 and prostate carcinoma: There are two other large randomised studies of prostate cancer screening: the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial did not find any significant reduction in prostate cancer mortality when the control arm included high levels of opportunistic PSA testing [8].